Numerous somatic mutations, including cancer-associated mutations in ARID1A, ATM, CDH4, NRAS, and PIK3CA, were shared among the epithelium from the uterine endometrium, endometriotic lesions distant from and adjacent to the carcinoma, and the carcinoma itself. This evidence concerns the gene ARID1A and cancer.